Aripiprazole loaded PLGA nanoparticles for controlled release studies: Effect of Co-polymer ratio

Authors

  • Chandra Babu Department of Chemistry, Sri Krishnadevaraya University, Anantapur-515 003, India
  • P Kumara Babu Department of Polymer Science & Technology, Sri Krishnadevaraya University, Anantapur-515 003, India
  • K Sudhakar Department of Polymer Science & Technology, Sri Krishnadevaraya University, Anantapur-515 003, India
  • MCS. Subha Department of Chemistry, Sri Krishnadevaraya University, Anantapur-515 003, India
  • K Chowdoji Rao Department of Polymer Science & Technology, Sri Krishnadevaraya University, Anantapur-515 003, India

Keywords:

PLGA Nanoparticles, Co-polymer Ratio, Controlled drug delivery

Abstract

Poly (lactic-co-glycolic acid) nanoparticles loaded with Aripiprazole has been developed as a new therapeutic strategy to achieve its controlled release profile suitable for parenteral administration. Nanospheres composed of different lactic/glycolic acid ratios and drug compositions were synthesized and loaded with Aripiprazole by emulsion/solvent evaporation method and subsequently characterized by particle-size distribution, scanning electron microscopy, encapsulation efficiency and inăvitro drug release studies. Specific drug-polymer interactions are engineered by optimizing the lactide to glycolide ratio (L:G ratio) and including specific polymer hydrophobicity

References

. Langer R. Drug delivery and

targeting. Nature 1998; 392:5ă10.

. Woo BH, Jiang G, Yeong W,

DeLuca PP. Preparation and

characterization of a composite

PLGA and poly(acryloyl

hydroxyethyl starch) microsphere

system for protein delivery. Pharm.

Res. 2001; 18:1600-1606.

. Dong HN, Youna YS, Leea SD,

Sonb MW, Kimb WB, DeLucac PP,

leea KC. Monitoring of peptide

acylation inside degrading PLGA

microspheres by capillary

electrophoresis and MALDI-TOF

mass spectrometry. J. Control.

Release 2003; 92:291-299.

. Mu L, Feng SS. A novel controlled

release formulation for the

anticancer drug paclitaxel (Taxol):

PLGA nanoparticles containing

vitamin E TPGS. J. Control. Release

; 86:33-48.

. Okada H, Toguchi H. Biodegradable

microspheres in drug delivery. Crit.

Rev. Ther. Drug Carrier Syst. 1995;

:1-99.

. Barratt G. Colloidal drug

carriers: achievements and

perspectives. Cell. Mol. Life Sci.

; 60:21-37.

. Lam XM, Duenas ET, Daugherty AL,

Levin N, Cleland JL. Sustained

release of recombinant human

insulin-like growth factor-1 for

treatment of diabetes. J. Control.

Release 2000;67: 281-292.

. Cohen S, Yoshioka T, Lucarelli M,

Hwang LH, Langer R. Controlled

delivery systems for proteins based

on poly(lactic/glycolic acid)

microspheres. Pharm. Res.

;8:713-720.

. Whittlesey KJ, Shea LD. Delivery

systems for small molecule drugs,

proteins, and DNA: the

neuroscience/biomaterial interface.

Exp. Neurol. 2004; 190: 1-16.

. Lagarce F, Faisant N, Desfontis JC,

Marescaux L, Gauiter F, Richerd J.

Baclofen-loaded microspheres in gel

suspensions for intrathecal

drugdelivery: In vitro and in

vivo evaluation. Eur. J. Pharm.

Biopharm. 2005;61: 171-180.

. Shive MS, Anderson JM.

Biodegradation and biocompatibility

of PLA and PLGA microspheres.

Adv. Drug Deliv. Rev. 1997;28: 5-

. Gabor F, Ertl B, Wirth M, Mallinger

R. Ketoprofen-poly(D,L-lactic-coglycolic acid) microspheres:

influence of manufacturing

parameters and type of polymer on

the release characteristics. J.

Microencapsul. 1999;16: 1-12.

. Gavin MC, Goa KL. Aripiprazole.

CNS Drugs 2002;16: 779-786.

. Burris KD, Moiski TF. Aripiprazole, a

novel antipsychotic, is a high-affinity

partial agonist at human dopamine

D2 receptors.J. Pharmacol. Exp.

Ther. 2002;302: 381-389.

. Goodnuck PJ, Jerry JM.

Aripiprazole: profile on efficacy and

safety. Expert Opinion on

Pharmacotherapy 2002;12: 1773-

. Nidhin M, Indumathy R, Sreeram K,

Nair B. Synthesis of iron oxide

nanoparticles of narrow size

distribution on polysaccharide

templates. Bull. Mater. Sci. 2008;31:

-96.

. Panyam J, Williams D, Dash A,

Leslie-Pelecky D, Labbasetwar V.

Solid-state solubility influences

encapsulation and release of

hydrophobic drugs from PLGA/PLA

nanoparticles. J. Pharm. Sci.

;93: 1804-1814.

. Kosmidis K, Rinaki E, Argyrakis P,

Macheras P. Analysis of Case II

drug transport with radial and axial

release from cylinders. Int. J.

Pharm. 2003;254: 183-188.

. Ritger PL, Peppas NA. A Simple

Equation for Description of Solute

Release. I. Fickian and non-Fickian

Release from Non-Swellable

Devices in the Form of Slabs,

Spheres, Cylinders or Discs. J.

Control. Release 1987;5: 23-36.

. Ritger PL, Peppas NA. A Simple

Equation for Description of Solute

Release. II. Fickian and Anomalous

Release from Swellable Devices. J.

Control. Release 1987;5: 37-42.

. Huang X, Brazel CS. On the

importance and mechanisms of

burst release in matrix-controlled

drug delivery systems. J. Control.

Release 2001;73: 121-136

Downloads

Published

2014-06-30

How to Cite

Chandra Babu, P Kumara Babu, K Sudhakar, MCS. Subha, & K Chowdoji Rao. (2014). Aripiprazole loaded PLGA nanoparticles for controlled release studies: Effect of Co-polymer ratio. International Journal of Drug Delivery, 6(2), 151–155. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/240

Issue

Section

Original Research Articles